查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869923

乳房影像市場規模、佔有率和趨勢分析報告：按技術、應用、地區和細分市場預測（2025-2030 年）

Breast Imaging Market Size, Share & Trends Analysis Report By Technology (Ionizing, Non Ionizing), By End-use (Hospitals, Breast Care Centers, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 97 Pages | 商品交期: 2-10個工作天內

價格

乳房影像市場摘要

2024年全球乳房影像市場規模估計為54.5億美元，預計2030年將達到90億美元。

預計從 2025 年到 2030 年，乳房影像市場將以 8.9% 的複合年成長率成長。乳癌發病率上升、乳房影像領域的技術進步以及多家機構對乳癌篩檢計畫的投資等因素正在推動乳房影像市場的成長。

根據世界癌症研究基金會（WCRF）的數據，預計到2030年，全球整體乳癌病例將達到約210萬例。國際癌症研究機構（IARC）的一份新報告預測，到2050年，全球乳癌病例將增加38%，年死亡人數將增加68%。預計這一趨勢將在預測期內推動乳房影像市場的成長。

乳癌及其他乳房相關疾病發生率的不斷上升預計將顯著推動乳房影像市場的擴張。根據美國國家乳癌基金會（National 乳癌 Cancer Foundation, Inc.）2025年6月發布的數據，預計美國約有八分之一的女性在一生中會被診斷出罹患乳癌。此外，國際癌症研究機構（IARC）預測，2022年至2050年間，美國乳癌發生率將成長27.8%，到2050年將達到約350,693例。癌症病例數量的顯著成長預計將推動美國對乳房磁振造影（MRI）檢查的需求。

對混合成像系統開發的深入研究將帶來巨大的成長機會，並推動市場成長。影像技術的最新發展趨勢徹底改變了治療的性質和方法。結合電腦斷層掃描、MRI和PET掃描等影像技術來觀察器官代謝資料和解剖特徵變得日益重要。此外，這些整合顯像模式提高了乳房攝影品質、患者舒適度和輻射計量。這些優勢促使全球製造商致力於推出能夠提高乳癌診斷靈敏度和準確性的新產品。例如，2021年1月，森諾醫療器材公司（Seno Medical Instruments）的乳癌診斷影像技術獲得了美國食品藥物管理局（FDA）醫療設備與放射健康中心（CDRH）的上市前核准。這項新技術專門用於區分乳房良性和惡性病變。

此外，旨在評估用於癌症檢測的先進磁振造影(MRI) 技術並開發創新影像解決方案的臨床試驗不斷增加，預計將顯著促進乳房影像市場的成長。這些試驗對於提高診斷準確性、促進早期發現和檢驗新技術至關重要。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 乳房影像市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 乳房影像市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章 乳房影像市場：技術預測與趨勢分析

  • 細分儀表板
  • 全球乳房影像市場技術波動分析
  • 全球乳房影像市場規模及趨勢分析（依技術分類，2018-2030 年）
  • 電離
    • 全視野數位乳房攝影
    • 模擬乳房攝影
    • 正電子放射乳房攝影術
    • 電電阻掃描
    • 錐狀射束CT
    • 正子斷層掃描和電腦斷層掃描
    • 3D乳房斷層合成
    • MBI/BSGI
  • 非離子化
    • MRI
    • 熱成像
    • 超音波
    • 光學成像
    • 自動全乳超音波

第5章 乳房影像：最終用途估算與趨勢分析

  • 細分儀表板
  • 全球乳房影像市場終端用途差異分析
  • 全球乳房影像市場規模及趨勢分析（按最終用途分類）（2018-2030 年）
  • 醫院
  • 診斷影像中心
  • 乳癌護理中心

第6章 乳房影像市場：區域估算與趨勢分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商概況
    • 主要經銷商和通路合作夥伴名單
    • 主要客戶
    • 2024年主要企業市佔率分析
    • GE HealthCare
    • Siemens Healthineers
    • Philips Healthcare
    • Canon Medical Systems
    • Fujifilm Healthcare
    • Aurora Imaging Technology, Inc.
    • Dilon Technologies, Inc.
    • Toshiba Corporation
    • SonoCine, Inc.
    • Gamma Medica, Inc
    • Hologic, Inc.
  • 熱力圖分析/企業市場分析
  • 2024年企業市佔率預測分析
  • 其他主要市場公司名單
Product Code: 978-1-68038-146-7

Breast Imaging Market Summary

The global breast imaging market size was estimated at USD 5.45 billion in 2024 and is projected to reach USD 9.00 billion by 2030, growing at a CAGR of 8.9% from 2025 to 2030. Factors such as the rising prevalence of breast cancer, technological breakthroughs in the domain of breast imaging, and investment from several organizations in breast cancer screening programs drive the breast imaging market.

According to the World Cancer Research Fund (WCRF), by 2030, the number of cases of breast cancer is expected to reach about 2.1 million globally. According to a new report from the International Agency for Research on Cancer (IARC), breast cancer cases are expected to increase by 38 percent globally by 2050, with annual deaths from the disease projected to rise by 68 percent. This aspect is expected to contribute to the growth of the breast imaging market over the forecast period.

The growing prevalence of breast cancer and other breast-related abnormalities is expected to drive the expansion of the breast imaging market significantly. According to data published by the National Breast Cancer Foundation, Inc. in June 2025, approximately 1 in 8 women in the U.S. is expected to be diagnosed with breast cancer during their lifetime. In addition, projections from the International Agency for Research on Cancer estimate a 27.8% increase in breast cancer incidence in the U.S. between 2022 and 2050, with cases expected to reach approximately 350,693 by 2050. This substantial rise in cancer cases is anticipated to fuel the demand for breast magnetic resonance imaging procedures across the country.

Widespread research in the development of hybrid imaging systems provides high growth opportunities and also aids the market growth. Recent developments in imaging technology have completely revolutionized the nature of treatment and how it is approached. To view the metabolic data and anatomical characteristics of the organs, it has become more crucial to combine imaging methods such as CT scans, MRIs, PET, and others. Furthermore, the quality of breast pictures, patient comfort, and patient dose have all been enhanced by these integrated imaging modalities. Thereby, owing to these advantages, manufacturers across the globe are concentrating more on the introduction of new products to improve the sensitivity and precision of breast cancer diagnostics. For instance, in January 2021, Seno Medical Instruments obtained premarket approval from The Center for Devices and Radiological Health in the U.S. for its diagnostic breast cancer imaging technology. The novel technology specialized in differentiating malignant and benign breast lesions.

Furthermore, the increasing number of clinical trials aimed at evaluating advanced magnetic resonance imaging modalities for cancer detection and developing innovative imaging solutions is expected to contribute significantly to the growth of the breast imaging market. These trials are crucial in improving diagnostic accuracy, enhancing early detection, and validating new technologies.

Global Breast Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global breast imaging market report based on technology, end-use, and region:

  • Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • Ionizing
    • Full-field Digital Mammography
    • Analog Mammography
    • Positron Emission Mammography
    • Electric Impedance Tomography
    • Cone-beam Computed Tomography
    • Positron Emission Tomography & Computed Tomography
    • 3D Breast Tomosynthesis
    • MBI/BSGI
  • Non Ionizing
    • MRI
    • Thermography
    • Ultrasound
    • Optical Imaging
    • Automated Whole-Breast Ultrasound
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Breast Care Centers
  • Diagnostic Imaging Centers
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Breast Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of breast cancer
      • 3.2.1.2. Technological advancements in the field of breast imaging
      • 3.2.1.3. Investments and initiatives from various organizations in breast cancer screening campaigns
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Risk of adverse effects from radiation exposure
      • 3.2.2.2. High cost of imaging systems
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Growing number of clinical trials
      • 3.2.3.2. Growing awareness of early detection
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Shortage of trained radiologists
  • 3.3. Breast Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Breast Imaging Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Breast Imaging Market Technology Movement Analysis
  • 4.3. Global Breast Imaging Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. Ionizing
    • 4.4.1. Ionizing market estimates and forecasts for 2018 to 2030 (USD Million)
    • 4.4.2. Full-Field Digital Mammography
      • 4.4.2.1. Full-field digital mammography market estimates and forecasts for 2018 to 2030 (USD Million)
    • 4.4.3. Analog Mammography
      • 4.4.3.1. Analog mammography market estimates and forecasts for 2018 to 2030 (USD Million)
    • 4.4.4. Positron Emission Mammography
      • 4.4.4.1. Positron emission mammography market estimates and forecasts for 2018 to 2030 (USD Million)
    • 4.4.5. Electric Impedance Tomography
      • 4.4.5.1. Electric impedance tomography market estimates and forecasts for 2018 to 2030 (USD Million)
    • 4.4.6. Cone-Beam Computed Tomography
      • 4.4.6.1. Cone-beam computed tomography market estimates and forecasts for 2018 to 2030 (USD Million)
    • 4.4.7. Positron Emission Tomography & Computed Tomography
      • 4.4.7.1. Positron emission tomography & computed tomography market estimates and forecasts for 2018 to 2030 (USD Million)
    • 4.4.8. 3D Breast Tomosynthesis
      • 4.4.8.1. 3D breast tomosynthesis market estimates and forecasts for 2018 to 2030 (USD Million)
    • 4.4.9. MBI/BSGI
      • 4.4.9.1. MBI/BSGI market estimates and forecasts for 2018 to 2030 (USD Million)
  • 4.5. Non Ionizing
    • 4.5.1. Non Ionizing market estimates and forecasts for 2018 to 2030 (USD Million)
    • 4.5.2. MRI
      • 4.5.2.1. MRI market estimates and forecasts for 2018 to 2030 (USD Million)
    • 4.5.3. Thermography
      • 4.5.3.1. Thermography market estimates and forecasts for 2018 to 2030 (USD Million)
    • 4.5.4. Ultrasound
      • 4.5.4.1. Ultrasound market estimates and forecasts for 2018 to 2030 (USD Million)
    • 4.5.5. Optical Imaging
      • 4.5.5.1. Optical imaging market estimates and forecasts for 2018 to 2030 (USD Million)
    • 4.5.6. Automated Whole-Breast Ultrasound
      • 4.5.6.1. Automated whole-breast ultrasound market estimates and forecasts for 2018 to 2030 (USD Million)

Chapter 5. Breast Imaging: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Breast Imaging Market End Use Movement Analysis
  • 5.3. Global Breast Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecasts for 2018 to 2030 (USD Million)
  • 5.5. Diagnostic Imaging Centers
    • 5.5.1. Diagnostic imaging centers market estimates and forecasts for 2018 to 2030 (USD Million)
  • 5.6. Breast Care Centers
    • 5.6.1. Breast care centers market estimates and forecasts for 2018 to 2030 (USD Million)

Chapter 6. Breast Imaging Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Competitive scenario
      • 6.3.2.3. Regulatory framework
      • 6.3.2.4. Reimbursement scenario
      • 6.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Competitive scenario
      • 6.3.3.3. Regulatory framework
      • 6.3.3.4. Reimbursement scenario
      • 6.3.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Competitive scenario
      • 6.4.1.3. Regulatory framework
      • 6.4.1.4. Reimbursement scenario
      • 6.4.1.5. UK market estimates and forecasts, 2018 - 2030
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Competitive scenario
      • 6.4.2.3. Regulatory framework
      • 6.4.2.4. Reimbursement scenario
      • 6.4.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Competitive scenario
      • 6.4.3.3. Regulatory framework
      • 6.4.3.4. Reimbursement scenario
      • 6.4.3.5. France market estimates and forecasts, 2018 - 2030
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Competitive scenario
      • 6.4.4.3. Regulatory framework
      • 6.4.4.4. Reimbursement scenario
      • 6.4.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Competitive scenario
      • 6.4.5.3. Regulatory framework
      • 6.4.5.4. Reimbursement scenario
      • 6.4.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 6.4.6. Denmark
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Competitive scenario
      • 6.4.6.3. Regulatory framework
      • 6.4.6.4. Reimbursement scenario
      • 6.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Competitive scenario
      • 6.4.7.3. Regulatory framework
      • 6.4.7.4. Reimbursement scenario
      • 6.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Competitive scenario
      • 6.4.8.3. Regulatory framework
      • 6.4.8.4. Reimbursement scenario
      • 6.4.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement scenario
      • 6.5.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 6.5.2. India
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. India market estimates and forecasts, 2018 - 2030
    • 6.5.3. China
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. China market estimates and forecasts, 2018 - 2030
    • 6.5.4. South Korea
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Competitive scenario
      • 6.5.4.3. Regulatory framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Competitive scenario
      • 6.5.5.3. Regulatory framework
      • 6.5.5.4. Reimbursement scenario
      • 6.5.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Competitive scenario
      • 6.5.6.3. Regulatory framework
      • 6.5.6.4. Reimbursement scenario
      • 6.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement scenario
      • 6.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
    • 6.6.3. Mexico
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Mexico market estimates and forecasts, 2018 - 2030
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Global Key company market share analysis, 2024
    • 7.3.4. GE HealthCare
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Siemens Healthineers
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Philips Healthcare
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Canon Medical Systems
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Fujifilm Healthcare
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Aurora Imaging Technology, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Dilon Technologies, Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Toshiba Corporation
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. SonoCine, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Gamma Medica, Inc
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Hologic, Inc.
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
  • 7.4. Heat Map Analysis/ Company Market Position Analysis
  • 7.5. Estimated Company Market Share Analysis, 2024
  • 7.6. List of Other Key Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America breast imaging market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America breast imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 7 U.S breast imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 Canada breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 9 Canada breast imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Mexico breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Mexcio breast imaging market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe breast imaging market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Europe breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 15 UK breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 16 UK breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Germany breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 19 France breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 20 France breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Italy breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Italy breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Spain breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Spain breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Sweden breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Sweden breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Denmark breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 28 Denmark breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Norway breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Norway breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific breast imaging market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Japan breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Japan breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 36 China breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 37 China breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 38 India breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 39 India breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Australia breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Australia breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 42 South Korea breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 43 South Korea breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Thailand breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Thailand breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Latin America breast imaging market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Latin America breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Brazil breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Brazil breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Argentina breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Argentina breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa breast imaging market, by country, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Africa breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 57 South Africa breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 60 UAE breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 61 UAE breast imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait breast imaging market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Kuwait breast imaging market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Breast imaging market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market summary (2024)
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Reimbursement pathway
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Breast imaging market: Technology movement analysis
  • Fig. 17 Breast imaging market technology outlook: Key takeaways
  • Fig. 18 Ionizing market, 2018 - 2030 (USD Million)
  • Fig. 19 Full-field digital mammography market, 2018 - 2030 (USD Million)
  • Fig. 20 Analog mammography market, 2018 - 2030 (USD Million)
  • Fig. 21 Positron emission mammography market, 2018 - 2030 (USD Million)
  • Fig. 22 Electric impedance tomography market, 2018 - 2030 (USD Million)
  • Fig. 23 Cone-beam computed tomography market, 2018 - 2030 (USD Million)
  • Fig. 24 Positron emission tomography & computed tomography market, 2018 - 2030 (USD Million)
  • Fig. 25 3D breast tomosynthesis market, 2018 - 2030 (USD Million)
  • Fig. 26 MBI/BSGI market, 2018 - 2030 (USD Million)
  • Fig. 27 Non Ionizing market, 2018 - 2030 (USD Million)
  • Fig. 28 MRI market, 2018 - 2030 (USD Million)
  • Fig. 29 Thermography market, 2018 - 2030 (USD Million)
  • Fig. 30 Ultrasound market, 2018 - 2030 (USD Million)
  • Fig. 31 Optical imaging market, 2018 - 2030 (USD Million)
  • Fig. 32 Automated whole-breast ultrasound market, 2018 - 2030 (USD Million)
  • Fig. 33 Regional Outlook, 2022 & 2030
  • Fig. 34 Regional market: Key takeaways
  • Fig. 35 North America breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 39 UK breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 41 France breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 46 Norway breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 48 Japan breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 49 China breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 50 India breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 51 Australia breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East & Africa breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE breast imaging market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait breast imaging market, 2018 - 2030 (USD Million)